| Neurotoxic reactive astrocytes are induced by activated microglia SA Liddelow, KA Guttenplan, LE Clarke, FC Bennett, CJ Bohlen, ... Nature 541 (7638), 481-487, 2017 | 4902 | 2017 |
| Single-cell genomics identifies cell type–specific molecular changes in autism D Velmeshev, L Schirmer, D Jung, M Haeussler, Y Perez, S Mayer, ... Science 364 (6441), 685-689, 2019 | 522 | 2019 |
| Potassium channel KIR4. 1 as an immune target in multiple sclerosis R Srivastava, M Aslam, SR Kalluri, L Schirmer, D Buck, B Tackenberg, ... New England Journal of Medicine 367 (2), 115-123, 2012 | 398 | 2012 |
| Neuronal vulnerability and multilineage diversity in multiple sclerosis L Schirmer, D Velmeshev, S Holmqvist, M Kaufmann, S Werneburg, ... Nature 573 (7772), 75-82, 2019 | 333 | 2019 |
| Thrombus histology suggests cardioembolic cause in cryptogenic stroke T Boeckh-Behrens, JF Kleine, C Zimmer, F Neff, F Scheipl, J Pelisek, ... Stroke 47 (7), 1864-1871, 2016 | 223 | 2016 |
| The impact of histological clot composition in embolic stroke T Boeckh-Behrens, M Schubert, A Förschler, S Prothmann, K Kreiser, ... Clinical neuroradiology 26, 189-197, 2016 | 184 | 2016 |
| Risk of thrombus fragmentation during endovascular stroke treatment J Kaesmacher, T Boeckh-Behrens, S Simon, C Maegerlein, JF Kleine, ... American Journal of Neuroradiology 38 (5), 991-998, 2017 | 143 | 2017 |
| Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology N Deigendesch, L Sironi, M Kutza, S Wischnewski, V Fuchs, J Hench, ... Acta neuropathologica 140, 583-586, 2020 | 118 | 2020 |
| Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis L Schirmer, JP Antel, W Brück, C Stadelmann Brain pathology 21 (4), 428-440, 2011 | 113 | 2011 |
| Gut microbiota–specific IgA+ B cells traffic to the CNS in active multiple sclerosis AK Pröbstel, X Zhou, R Baumann, S Wischnewski, M Kutza, OL Rojas, ... Science immunology 5 (53), eabc7191, 2020 | 104 | 2020 |
| Kir4. 1-dependent astrocyte-fast motor neuron interactions are required for peak strength KW Kelley, LB Haim, L Schirmer, GE Tyzack, M Tolman, JG Miller, ... Neuron 98 (2), 306-319. e7, 2018 | 99 | 2018 |
| Reactive astrocyte COX2‐PGE2 production inhibits oligodendrocyte maturation in neonatal white matter injury LR Shiow, G Favrais, L Schirmer, AL Schang, S Cipriani, C Andres, ... Glia 65 (12), 2024-2037, 2017 | 91 | 2017 |
| Enriched CD161high CCR6+ γδ T cells in the cerebrospinal fluid of patients with multiple sclerosis L Schirmer, V Rothhammer, B Hemmer, T Korn JAMA neurology 70 (3), 345-351, 2013 | 78 | 2013 |
| Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas M Friedrich, R Sankowski, L Bunse, M Kilian, E Green, ... Nature Cancer 2 (7), 723-740, 2021 | 77 | 2021 |
| Oligodendrocyte-encoded Kir4. 1 function is required for axonal integrity L Schirmer, W Möbius, C Zhao, A Cruz-Herranz, L Ben Haim, C Cordano, ... Elife 7, e36428, 2018 | 73 | 2018 |
| Thrombus permeability in admission computed tomographic imaging indicates stroke pathogenesis based on thrombus histology M Berndt, B Friedrich, C Maegerlein, S Moench, D Hedderich, M Lehm, ... Stroke 49 (11), 2674-2682, 2018 | 71 | 2018 |
| Substantial early, but nonprogressive neuronal loss in multiple sclerosis (MS) spinal cord L Schirmer, M Albert, A Buss, WJ Schulz‐Schaeffer, JP Antel, W Brück, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 62 | 2009 |
| Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions L Schirmer, D Merkler, FB König, W Brück, C Stadelmann Brain Pathology 23 (1), 2-12, 2013 | 57 | 2013 |
| The radiologically isolated syndrome: take action when the unexpected is uncovered? J Sellner, L Schirmer, B Hemmer, M Mühlau Journal of neurology 257, 1602-1611, 2010 | 56 | 2010 |
| The intratumoral heterogeneity reflects the intertumoral subtypes of glioblastoma multiforme: a regional immunohistochemistry analysis N Bergmann, C Delbridge, J Gempt, A Feuchtinger, A Walch, L Schirmer, ... Frontiers in oncology 10, 494, 2020 | 52 | 2020 |
